Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
The Top 3 Healthcare Stocks to Buy in March 2024
12:27pm, Thursday, 07'th Mar 2024
Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.
Charles River (CRL) Forges Collaboration With Wheeler Bio
09:46am, Monday, 26'th Feb 2024
Charles River (CRL) and Wheeler Bio join forces to accelerate the journey from discovery and CMC development to manufacturing.
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
11:41am, Wednesday, 21'st Feb 2024
Within DSA, Charles River (CRL) is currently the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript
01:19pm, Wednesday, 14'th Feb 2024
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript
Charles River (CRL) Q4 Earnings Surpass, Margins Contract
10:31am, Wednesday, 14'th Feb 2024
Charles River (CRL) delivers better-than-expected revenues and earnings in the fourth quarter of 2023.
Here's Why You Should Retain Charles River (CRL) Stock Now
09:21am, Tuesday, 13'th Feb 2024
Charles River's (CRL) share price is likely to grow, backed by the strength of the RMS segment.
Unveiling Charles River (CRL) Q4 Outlook: Wall Street Estimates for Key Metrics
10:21am, Friday, 09'th Feb 2024
Get a deeper insight into the potential performance of Charles River (CRL) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates
Charles River (CRL) to Report Q4 Earnings: What's in Store?
11:11am, Thursday, 01'st Feb 2024
The service business within Charles River (CRL) RMS is expected to have witnessed growth in the fourth quarter, banking on small molecule revenue increase across several geographic regions.
Charles River (CRL) Launches Animal-Free Endotoxin Test
02:41pm, Tuesday, 30'th Jan 2024
Charles River's (CRL) latest launch expands on Charles River's existing Trillium rCR vial product.
Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
04:30pm, Tuesday, 23'rd Jan 2024
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call.
Here's Why You Should Retain Charles River (CRL) Stock Now
03:47pm, Friday, 12'th Jan 2024
Investors are optimistic about Charles River (CRL) owing to growth in the RMS and DSA segments and stable solvency position.
Charles River's (CRL) Memphis Site Achieves Crucial Approval
09:02am, Tuesday, 19'th Dec 2023
Charles River (CRL) reaches an important milestone in cell therapy manufacturing collaboration with Vertex Pharmaceuticals.
Charles River (CRL) Expands 3D In Vitro Services Via New Deal
09:47am, Wednesday, 13'th Dec 2023
Charles River (CRL) finalizes agreement with service-based biotechnology company, CELLphenomics.
Investing in the Aging Population: 3 Healthcare Stocks to Watch
01:53pm, Thursday, 07'th Dec 2023
In 2016, there were 49 million Americans aged 65 or older. Analysts forecast that will grow to 73 million retirement-age Americans in 2030 and an eye-opening 95 million in the year 2060.
Here's Why You Should Retain Charles River (CRL) Stock Now
09:01am, Tuesday, 05'th Dec 2023
Charles River's (CRL) share price is likely to grow, backed by the strength of the DSA segment.
